Literature DB >> 2572604

Use of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa.

D P Speert1, M E Campbell, S W Farmer, K Volpel, A M Joffe, W Paranchych.   

Abstract

Strains of Pseudomonas aeruginosa from patients with cystic fibrosis (CF) are unusual. The majority have a rough lipopolysaccharide (LPS) which renders them nontypeable by conventional typing systems based on a serological reaction with the O polysaccharide of smooth LPS. We developed a new typing scheme using a pilin gene probe as a marker for hybridization with endonuclease-digested genomic DNA from P. aeruginosa. Twenty-one different restriction fragment length polymorphism (RFLP) types were found among 249 isolates. RFLP type 7 was recovered only from patients with thermal burns (9 of 14 isolates) in both Vancouver, British Columbia, and Edmonton, Alberta, Canada. None of the other RFLP types showed a clear predilection for disease state or environmental niche. Multiple morphologically different isolates from individual patients with CF were studied; each isolate in 33 of 40 sputum samples had an identical RFLP type, despite considerable LPS serotype heterogeneity. Sequential isolates from 23 patients were studied; in 10 isolates there was a clear change in both the RFLP and the LPS serotype. We conclude that patients with CF usually harbor a single P. aeruginosa RFLP type in their sputa, but that one strain can replace another as the predominant colonizing type.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2572604      PMCID: PMC267081          DOI: 10.1128/jcm.27.11.2589-2593.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  THE IDENTIFICATION OF ATYPICAL STRAINS OF PSEUDOMONAS AERUGINOSA.

Authors:  A H WAHBA; J H DARRELL
Journal:  J Gen Microbiol       Date:  1965-03

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

Review 3.  Cystic fibrosis.

Authors:  R E Wood; T F Boat; C F Doershuk
Journal:  Am Rev Respir Dis       Date:  1976-06

4.  New immunotype schema for Pseudomonas aeruginosa based on protective antigens.

Authors:  M W Fisher; H B Devlin; F J Gnabasik
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

Review 5.  Review: ethidium fluorescence assays. Part 1. Physicochemical studies.

Authors:  A R Morgan; J S Lee; D E Pulleyblank; N L Murray; D H Evans
Journal:  Nucleic Acids Res       Date:  1979-10-10       Impact factor: 16.971

6.  Pseudomonas aeruginosa in a center for cancer research. I. Distribution of intraspecies types from human and environmental sources.

Authors:  M R Moody; V M Young; D M Kenton; G D Vermeulen
Journal:  J Infect Dis       Date:  1972-02       Impact factor: 5.226

7.  An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. I. Clinical studies.

Authors:  K Crossley; D Loesch; B Landesman; K Mead; M Chern; R Strate
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

8.  Multiple of isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis.

Authors:  M J Thomassen; C A Demko; B Boxerbaum; R C Stern; P J Kuchenbrod
Journal:  J Infect Dis       Date:  1979-12       Impact factor: 5.226

9.  Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains.

Authors:  D Grothues; U Koopmann; H von der Hardt; B Tümmler
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

10.  New selective medium for Pseudomonas aeruginosa with phenanthroline and 9-chloro-9-[4-(diethylamino)phenyl]-9,10-dihydro-10- phenylacridine hydrochloride (C-390).

Authors:  M E Campbell; S W Farmer; D P Speert
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

View more
  28 in total

1.  Molecular epidemiological analysis of Pseudomonas aeruginosa strains causing failure of antibiotic therapy in cystic fibrosis patients.

Authors:  E Bingen; E Denamur; B Picard; P Goullet; N Lambert-Zechovsky; P Foucaud; J Navarro; J Elion
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

2.  Genetic heterogeneity in strains of Pseudomonas aeruginosa from patients with cystic fibrosis.

Authors:  J W Ogle; M L Vasil
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

3.  Heterogeneity, persistence, and distribution of Pseudomonas aeruginosa genotypes in cystic fibrosis patients.

Authors:  M Fegan; P Francis; A C Hayward; J A Fuerst
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

4.  Genome macrorestriction analysis of sequential Pseudomonas aeruginosa isolates from bronchiectasis patients without cystic fibrosis.

Authors:  S W Hla; K P Hui; W C Tan; B Ho
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

Review 5.  Lung infections. 3. Pseudomonas aeruginosa and other related species.

Authors:  R Wilson; R B Dowling
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

Review 6.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

7.  Genetic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis revealed by restriction fragment length polymorphism of the rRNA gene region.

Authors:  C Martin; M A Ichou; P Massicot; A Goudeau; R Quentin
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

8.  Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa.

Authors:  H Grundmann; C Schneider; D Hartung; F D Daschner; T L Pitt
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

9.  DNA-based diagnostic tests for Salmonella species targeting agfA, the structural gene for thin, aggregative fimbriae.

Authors:  J L Doran; S K Collinson; J Burian; G Sarlós; E C Todd; C K Munro; C M Kay; P A Banser; P I Peterkin; W W Kay
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

10.  Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients.

Authors:  M J Struelens; V Schwam; A Deplano; D Baran
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.